March 22, 2024BiomaterialsOpen Access

Engineered human osteoarthritic cartilage organoids

View Full Paper

Ask AI

Bookmark

Authors

LDLaura DöngesUniversity of Basel ADAtharva DamleUniversity of Basel AMAndrea MainardiUniversity of Basel

Discussion

Member takes

Implication

Experimental study demonstrates osteoarthritis traits in engineered human cartilage organoids, highlighting therapeutic targets for joint degeneration.

Key Points

Engineered cartilage organoids successfully model osteoarthritis hallmarks, displaying matrix mineralization and chondrocyte hypertrophy after inflammatory challenge.
Mass spectrometry-based proteomics demonstrates that interleukin 1 receptor antagonist suppresses transcription factor ccaat enhancer binding protein beta expression.
These human organotypic platforms may accelerate therapeutic screening for cartilage degeneration—in vitro organoid model; further preclinical validation remains necessary.

Cite This Study

Dönges et al. (2024) studied this question.

synapsesocial.com/papers/68e72b96b6db6435876a53c4 https://doi.org/10.1016/j.biomaterials.2024.122549

View Full Paper

Ask AI

Bookmark

Implication

Experimental study demonstrates osteoarthritis traits in engineered human cartilage organoids, highlighting therapeutic targets for joint degeneration.

Engineered human osteoarthritic cartilage organoids

Discussion

Member takes

Implication

Key Points

Cite This Study

Engineered human osteoarthritic cartilage organoids

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider